none 10.6061/clinics/2020/e1486 Elsevier BV Elsevier 78 115621627 45578 2025102811192900000 10.1016 2025-10-29T07:01:58Z 2020-04-15T10:17:42Z 48 Clinics Clinics 18075932 2020 75 C Yu-Xiao Zhao Yu-Wen Song Liang Zhang Feng-Jie Zheng Xue-Meng Wang Xiang-Hua Zhuang Fei Wu Jian Liu https://orcid.org/0000-0002-0801-6811 2020 e1486 S1807593222002940 e1486 S1807593222002940 10.1016/elsevier_cm_policy elsevier.com sciencedirect.com true Elsevier Association between bile acid metabolism and bone mineral density in postmenopausal women Clinics https://doi.org/10.6061/clinics/2020/e1486 article Copyright © 2020 CLINICS. Published by Elsevier Spain https://www.elsevier.com/tdm/userlicense/1.0/ https://www.elsevier.com/legal/tdmrep-license https://creativecommons.org/licenses/by/4.0/ 10.6061/clinics/2020/e1486 https://linkinghub.elsevier.com/retrieve/pii/S1807593222002940 https://api.elsevier.com/content/article/PII:S1807593222002940?httpAccept=text/xml https://api.elsevier.com/content/article/PII:S1807593222002940?httpAccept=text/plain https://dul.usage.elsevier.com/doi/ http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100218&lng=en&nrm=iso https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7061317/ https://www.clinicsjournal.com/article/association-between-bile-acid-metabolism-and-bone-mineral-density-in-postmenopausal-women/ Lancet Compston 393 10169 364 2019 10.1016/S0140-6736(18)32112-3 Osteoporosis Arch Osteoporos Yu 14 1 32 2019 10.1007/s11657-018-0549-y The epidemiology of osteoporosis, associated fragility fractures, and management gap in China N Engl J Med Black 374 21 2096 2016 Postmenopausal Osteoporosis Alzheimers Dement MahmoudianDehkordi 15 1 76 2019 10.1016/j.jalz.2018.07.217 Altered bile acid profile associates with cognitive impairment in Alzheimer's disease—An emerging role for gut microbiome Gastroenterology Chávez-Talavera 152 7 1679 2017 10.1053/j.gastro.2017.01.055 Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease Hepatology Loomes 69 1 245 2019 10.1002/hep.30196 Bone Density in Children With Chronic Liver Disease Correlates With Growth and Cholestasis J Bone Metab Zheng 24 4 207 2017 10.11005/jbm.2017.24.4.207 Fexaramine Inhibits Receptor Activator of Nuclear Factor-κB Ligand-induced Osteoclast Formation via Nuclear Factor of Activated T Cells Signaling Pathways J Bone Miner Res Li 34 4 765 2019 10.1002/jbmr.3652 Dual Targeting of Bile Acid Receptor-1 (TGR5) and Farnesoid X Receptor (FXR) Prevents Estrogen-Dependent Bone Loss in Mice Front Psychiatry Eriksson 9 781 2019 10.3389/fpsyt.2018.00781 Bone Status in Obese, Non-diabetic, Antipsychotic-Treated Patients, and Effects of the Glucagon-Like Peptide-1 Receptor Agonist Exenatide on Bone Turnover Markers and Bone Mineral Density Life Sci Xu 226 47 2019 10.1016/j.lfs.2019.04.013 Glucagon like peptide 2 has a positive impact on osteoporosis in ovariectomized rats J Bone Miner Res Cho 28 10 2109 2013 10.1002/jbmr.1961 Positive regulation of osteogenesis by bile acid through FXR Bone Id Boufker 49 6 1219 2011 10.1016/j.bone.2011.08.013 Role of farnesoid X receptor (FXR) in the process of differentiation of bone marrow stromal cells into osteoblasts Diabetes Bozadjieva 67 9 1720 2018 10.2337/dbi17-0007 Targeting FXR and FGF19 to Treat Metabolic Diseases-Lessons Learned From Bariatric Surgery Lancet Diabetes Endocrinol van Nierop 5 3 224 2017 10.1016/S2213-8587(16)30155-3 Clinical relevance of the bile acid receptor TGR5 in metabolism J Clin Endocrinol Metab Sonne 101 8 3002 2016 10.1210/jc.2016-1607 Postprandial Plasma Concentrations of Individual Bile Acids and FGF-19 in Patients With Type 2 Diabetes Trends Endocrinol Metab Molinaro 29 1 31 2018 10.1016/j.tem.2017.11.002 Role of Bile Acids in Metabolic Control Sci Rep Zhang 7 1 2017 Lowered fasting chenodeoxycholic acid correlated with the decrease of fibroblast growth factor 19 in Chinese subjects with impaired fasting glucose Diabetes Maczewsky 68 2 324 2019 10.2337/db18-0315 TGR5 Activation Promotes Stimulus-Secretion Coupling of Pancreatic β-Cells via a PKA-Dependent Pathway Bone Pereira 81 459 2015 10.1016/j.bone.2015.08.006 Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice J Bone Miner Res Ma 28 7 1641 2013 10.1002/jbmr.1898 Exendin-4, a glucagon-like peptide-1 receptor agonist, prevents osteopenia by promoting bone formation and suppressing bone resorption in aged ovariectomized rats Exp Cell Res Wu 360 2 281 2017 10.1016/j.yexcr.2017.09.018 Front Endocrinol Zhao 8 98 2017 10.3389/fendo.2017.00098 The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms Osteoporosis Int Wang 30 7 1491 2019 10.1007/s00198-019-04892-0 Discovery of potential biomarkers for osteoporosis using LC-MS/MS metabolomic methods Front Endocrinol Schiellerup 10 75 2019 10.3389/fendo.2019.00075 Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment